why choose us

Course: Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan

CME Credits: 1.00

Released: 2022-02-18

A recent meta-analysis, and a prospective study reported that bacterial coinfection and secondary infection among patients with COVID-19 infection are uncommon. However, in these studies, antimicrobial drugs were prescribed for approximately 70% of patients with the disease. Therefore, data are needed on patients with COVID-19 infection who do not routinely receive an antimicrobial drug prescription, to identify the true rate of concurrent infection in this patient population. At the National Hospital Organization Tochigi Medical Center in Utsunomiya, Tochigi, Japan, since the beginning of the COVID-19 pandemic, antimicrobial drugs have not been prescribed for patients with COVID-19 infection unless their symptoms are suggestive of another infectious disease. Therefore, we investigated the prevalence of antimicrobial drug use and concurrent infections among patients with COVID-19 during hospitalization.


Educational Objective
To identify the key insights or developments described in this article


View Full Course